Literature DB >> 26995162

Increased follistatin associated with decreased gait speed among old adults.

Fang-Yih Liaw1, Tung-Wei Kao1,2, Wen-Hui Fang1, Der-Sheng Han2,3, Yu-Chiao Chi2, Wei-Shiung Yang2,4,5,6.   

Abstract

BACKGROUND: Low gait speed is associated with inflammation and muscle strength. Follistatin, a glycosylated plasma protein, is involved in inflammatory diseases, bone metabolism, muscle strength and cognition. However, research regarding the relationship between follistatin and gait speed in elderly individuals is limited. In this study, we aimed to examine the association between follistatin and gait speed in older adults.
METHODS: This cross-sectional, observational study included 205 ambulatory individuals aged ≥ 65 years. The baseline measures included 15-foot walking time, a structured questionnaire, grip strength and biomarkers, including follistatin and myostatin levels. Multiple linear regression was used to determine the change in gait speed for each 1 pg/mL increase in serum follistatin level. An extended model approach with a quartile-based analysis of serum follistatin levels was conducted.
RESULTS: In the linear regression model, the β coefficient, representing the change in gait speed for each 1 pg/mL increase in serum follistatin level, was -0·308 (P < 0·001). After additional adjustment for relevant covariates, the β coefficient changed slightly, although the negative correlation remained (all P ≤ 0·001). After controlling for multiple covariates, participants in the highest serum follistatin level quartile had a significantly lower gait speed than those in the lowest quartile (all P for trend < 0·001).
CONCLUSIONS: A higher follistatin level was independently associated with lower gait speed in community-dwelling elderly individuals; this suggests that serum follistatin level may be an indicator of mobility in elderly persons and may more particularly represent lower extremity function.
© 2016 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Ageing; follistatin; gait speed; inflammation

Mesh:

Substances:

Year:  2016        PMID: 26995162     DOI: 10.1111/eci.12595

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

Review 1.  Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults.

Authors:  Richard D Semba; Qu Tian; Michelle C Carlson; Qian-Li Xue; Luigi Ferrucci
Journal:  Ageing Res Rev       Date:  2020-01-26       Impact factor: 10.895

2.  Objectively Measured Physical Activity in Asymptomatic Middle-Aged Men Is Associated With Routine Blood-Based Biomarkers.

Authors:  Karol M Pencina; Zhuoying Li; Monty Montano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-11-13       Impact factor: 6.053

3.  Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women.

Authors:  Yanping Du; Cuidi Xu; Hongli Shi; Xin Jiang; Wenjing Tang; Xiaoqing Wu; Minmin Chen; Huilin Li; Xuemei Zhang; Qun Cheng
Journal:  BMC Geriatr       Date:  2021-10-12       Impact factor: 3.921

Review 4.  Effect of Physical Activity/Exercise on Oxidative Stress and Inflammation in Muscle and Vascular Aging.

Authors:  Mariam El Assar; Alejandro Álvarez-Bustos; Patricia Sosa; Javier Angulo; Leocadio Rodríguez-Mañas
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

5.  Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men.

Authors:  Elizaveta Fife; Joanna Kostka; Łukasz Kroc; Agnieszka Guligowska; Małgorzata Pigłowska; Bartłomiej Sołtysik; Agnieszka Kaufman-Szymczyk; Krystyna Fabianowska-Majewska; Tomasz Kostka
Journal:  BMC Geriatr       Date:  2018-08-30       Impact factor: 3.921

6.  Comparisons of Muscle Quality and Muscle Growth Factor Between Sarcopenic and Non-Sarcopenic Older Women.

Authors:  Myong-Won Seo; Sung-Woo Jung; Sung-Woo Kim; Hyun Chul Jung; Deog-Yoon Kim; Jong Kook Song
Journal:  Int J Environ Res Public Health       Date:  2020-09-10       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.